Zymeworks receives FDA fast track designation for ovarian cancer drug

March 30, 2026 6:00 AM

Zymeworks Inc. (NASDAQ: ZYME) announced that the U.S. Food and Drug Administration has granted Fast Track designation to ZW191, an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found